Nestlé Health Science, a globally recognized leader in the field of nutritional science, has agreed to acquire the business of IM HealthScience with its brands of IBgard®, FDgard®, Fiber Choice® and REMfresh®.
“The IMH products offer proven and trusted solutions for dietary management of specific digestive problems as well as a separate solution for regulating sleep,” said Greg Behar, CEO of Nestlé Health Science. “IMH’s dedication to developing products to address overall health and wellness by bringing cutting-edge life science and world class research fits perfectly with our mission of empowering healthier lives through nutrition.”
IMH is the innovator of IBgard® and FDgard® for the dietary management of IBS (Irritable Bowel Syndrome) and FD (Functional Dyspepsia), respectively. In 2017, IMH added Fiber Choice®, a line of prebiotic fibers, to its product line via an acquisition. REMfresh® is a continuous release-and-absorption melatonin (CRA-melatonin) supplement for sleep.
Read the full press release